Pathophysiologies Involving Hemostasis-related Genes
涉及止血相关基因的病理生理学
基本信息
- 批准号:7052892
- 负责人:
- 金额:$ 176.05万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2004
- 资助国家:美国
- 起止时间:2004-05-01 至 2009-04-30
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
It is becoming increasingly clear that genes traditionally associated with hemostasis function in many other diverse pathophysiologic processes. Examples are the involvement of gene products related to fibrinolysis, e.g., plasminogen, plasminogen activators, and plasminogen activator inhibitors, with their roles in cancer, wound healing, and angiogenesis. These same genes, as well as products of genes of relevance to coagulation, e.g., Tissue Factor, and anticoagulation, e.g., Protein C, also function in embryogenesis, cancer, and acute and chronic inflammatory-based processes, among others. Thus, hemostasis-related genes serve as links between different pathways in health and disease. This Program Project Grant (PPG) builds on existing strengths and integrates the research efforts of experienced investigators who have made major contributions to our understanding of the protein chemistry, molecular and cell biology, gene targeting, and pathophysioiogies of proteins and genes associated with hemostasis. The focus of this PPG is the definition of the in vivo roles of hemostasis-related genes in: the relationships between disseminated intravascular coagulation, systemic inflammation, and organ damage during the progression of sepsis (Project by Castellino); tumorigenesis, metastasis, and angiogenesis (Project by Ploplis); and embryonic and perinatal survival of offspring, as well as in vivo thrombus formation (Project by Rosen). Three core units are proposed as necessary to
centrally support this group of projects: (1) an Administrative Core, (2) an Anatomic Pathology Core, and (3) a Mouse Breeding and Husbandry Core. The Project and Core Leaders have a long history of productive interactions with each other and are all based in an infrastructure-rich center devoted to in vivo and in vitro studies of coagulation, anticoagulation, and fibrinolysis. The projects proposed will utilize the same administrative, histopathology, and mouse cores. The PPG will allow increased interactions and collaborations to occur between the laboratories of the Project Leaders in studying the functional roles of hemostasis-related genes, and the overall program that results from these combined efforts will exceed the sum of the individual parts. The research efforts and productivity of students and postdoctorals will benefit greatly from the interactions of the individual laboratories and cores that will result from the PPG, and will
serve as a resource for a continual flow of independent investigations in these research areas.
越来越清楚的是,传统上与止血相关的基因在许多其他不同的病理生理过程中发挥作用。例子包括与纤维蛋白溶解相关的基因产物,例如纤溶酶原、纤溶酶原激活剂和纤溶酶原激活剂抑制剂,以及它们在癌症、伤口愈合和血管生成中的作用。这些相同的基因以及与凝血(例如组织因子)和抗凝血(例如蛋白 C)相关的基因的产物也在胚胎发生、癌症以及基于急性和慢性炎症的过程等中发挥作用。因此,止血相关基因充当健康和疾病不同途径之间的联系。该计划项目拨款(PPG)建立在现有优势的基础上,整合了经验丰富的研究人员的研究成果,他们为我们对蛋白质化学、分子和细胞生物学、基因靶向以及与止血相关的蛋白质和基因的病理生理学的理解做出了重大贡献。该 PPG 的重点是止血相关基因在体内作用的定义:脓毒症进展过程中弥散性血管内凝血、全身炎症和器官损伤之间的关系(Castellino 项目);肿瘤发生、转移和血管生成(Ploplis 项目);以及后代的胚胎和围产期存活,以及体内血栓形成(罗森项目)。根据需要提出三个核心单位
集中支持这组项目:(1) 管理核心,(2) 解剖病理学核心,以及 (3) 小鼠育种和饲养核心。项目和核心领导者之间有着悠久的富有成效的互动历史,并且都位于一个基础设施丰富的中心,致力于凝血、抗凝和纤溶的体内和体外研究。拟议的项目将利用相同的管理、组织病理学和小鼠核心。 PPG 将允许项目负责人的实验室之间在研究止血相关基因的功能作用方面加强互动和合作,并且这些共同努力所产生的总体计划将超过各个部分的总和。学生和博士后的研究工作和生产力将大大受益于 PPG 带来的各个实验室和核心之间的互动,并将
作为这些研究领域持续进行独立调查的资源。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
FRANCIS J CASTELLINO其他文献
FRANCIS J CASTELLINO的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('FRANCIS J CASTELLINO', 18)}}的其他基金
Blood Coagulation Protein - Metal Ion - Lipid Interactions
凝血蛋白-金属离子-脂质相互作用
- 批准号:
7819188 - 财政年份:2009
- 资助金额:
$ 176.05万 - 项目类别:
Pathophysiologies Involving Hemostasis-related Genes
涉及止血相关基因的病理生理学
- 批准号:
7406638 - 财政年份:2004
- 资助金额:
$ 176.05万 - 项目类别:
Pathophysiologies Involving Hemostasis-related Genes
涉及止血相关基因的病理生理学
- 批准号:
6757462 - 财政年份:2004
- 资助金额:
$ 176.05万 - 项目类别:
Pathophysiologies Involving Hemostasis-related Genes
涉及止血相关基因的病理生理学
- 批准号:
7229000 - 财政年份:2004
- 资助金额:
$ 176.05万 - 项目类别:
Pathophysiologies Involving Hemostasis-related Genes
涉及止血相关基因的病理生理学
- 批准号:
6885410 - 财政年份:2004
- 资助金额:
$ 176.05万 - 项目类别:
相似国自然基金
基于靶向代谢组学对携带MYH7基因突变的肥厚型心肌病患者不完全外显的机制研究
- 批准号:82371974
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
基于跨尺度自纠偏数字心脏的恶性基因突变智能预算方法研究
- 批准号:62306293
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
线粒体tRNA修饰酶GTPBP3基因突变引发肥厚型心肌病的机理研究
- 批准号:32300482
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于限位核酸和核酸内切酶IV的高灵敏ctDNA基因突变检测方法构建及其应用研究
- 批准号:82302651
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
DAGLB基因突变通过影响线粒体生物发生诱导铁死亡导致帕金森病发病的机制研究
- 批准号:82301618
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Development of epidermal progenitor cell-based therapy for regenerative medicine
开发基于表皮祖细胞的再生医学疗法
- 批准号:
9280088 - 财政年份:2017
- 资助金额:
$ 176.05万 - 项目类别:
Development of epidermal progenitor cell-based therapy for regenerative medicine
开发基于表皮祖细胞的再生医学疗法
- 批准号:
10091532 - 财政年份:2017
- 资助金额:
$ 176.05万 - 项目类别:
Mechanisms of airborne particulate matter induced thrombosis
空气颗粒物诱发血栓形成的机制
- 批准号:
7163087 - 财政年份:2006
- 资助金额:
$ 176.05万 - 项目类别:
Immunopathogenesis of Severe Malaria During Pregnancy
妊娠期严重疟疾的免疫发病机制
- 批准号:
7097558 - 财政年份:2006
- 资助金额:
$ 176.05万 - 项目类别: